<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

A Solid Recovery: Q122 Spine Market Recap

By Courtney Sheedy on 8/11/22 9:37 AM

Q122’s year-over-year growth in the WW Spine market shows normalized, nominal growth for this quarter, which should continue to improve over the course of the remaining year.

The US Spine Hardware market saw double-digit growth versus Q121, showing solid recovery gains from the same period prior year, which seemed to be riddled with ongoing volatility. Segment over segment within the spine market, we’re back to seeing growth in the areas that had been predicable growth segments prior to COVID-19. Although healthcare as a whole continues to rebuild, and staffing remains a challenge, many regions didn’t experience as negative an impact on the Spine market for Q122 as was predicted by many.

Among the many topics covered in detail in our comprehensive Q122 Spine Market Recap* are:

Continue Reading
3 min read

R92 Medical: Reimagining the Road to Stroke Interventions

By Anne Staylor on 8/9/22 9:30 AM

Adam Hattan, VP of Marketing for Route 92 Medical, discusses the Company, its novel system for mechanical thrombectomy and competing in the market for stroke interventions in an interview with SmartTRAK at SNIS 2022.

Amid a growing number of me-too devices, one company that is differentiating itself in the market for stroke thrombectomy is Route 92 Medical (R92). Adam Hattan, R92’s vice president of marketing, discusses R92’s novel system for mechanical thrombectomy and competing in the market for stroke interventions in an interview with SmartTRAK at the Society of Neurointerventional Surgery (SNIS) 19th Annual Meeting held in Toronto, Canada July 25-29, 2022.

To find out more about R92, its Monopoint operating platform and the Company’s strategies for growth, click on the following video recorded live at SNIS 2022.  (10:13 min). A link to download a transcript of the interview is also provided below.

Continue Reading
2 min read

New Spine Enabling Technologies: Q122 CAS Spine Market Recap

By Shelly Caruso on 8/5/22 12:15 PM

Although revenues still show signs of COVID-19 impact, robotic procedures and implant pull-through accelerate, and companies continue roll out new spine enabling technology and strategize how to maximize the remainder of 2022.

The Q122 WW CAS Spine Market was up year-over-year according to SmartTRAK Financial DashboardMedtronic* (MDT) remained the market leader with 59.5% share, followed by Globus* (GMED) and other enabling tech competitors, including Stryker* (SYK) and Brainlab*

Among the many topics covered in detail in our comprehensive Q122 CAS Spine Market Recap* are:

Continue Reading
2 min read

The Future of Biosensors and Smart Dressings in Wound Care Diagnostics

By Kris Flinn on 8/2/22 9:30 AM

Could biosensors and smart dressings be the final frontier in wound diagnostics? SmartTRAK explores the current progress of this market and how it could develop.

It has been 15 years since the World Union of Wound Healing Societies’ Initiative published a consensus document entitled “Diagnostics and Wounds.” Since then, the clinical practice around assessing and diagnosing wounds has not evolved at the same rate as that of treatments. At the same time, the need for improved wound diagnostics has never been greater given burgeoning chronic wound numbers and the continued shift of wound care services to the outpatient setting.

Could the next area of development be that of biosensors and smart dressings? SmartTRAK believes there is increasing evidence that this could be the case. In this article, we explore the developments that are taking place, how the identification of infection biomarkers may be lucrative and ways the market may change in the coming years.

Among the many topics discussed in this article are:

Topics: Wound Care
Continue Reading
2 min read

Healthy Growth w/ Mixed Results: Q122 Trauma Market Recap

By Natasha Weeks on 7/28/22 9:30 AM

Despite mixed results from Trauma players, the segment experienced healthy growth as mergers and acquisitions were plentiful and regulatory clearances show promise of future new product introductions.

Continue Reading
6 min read

Diagnostic and Digital Devices on Display: WOCNext 2022

By Gary Delhougne on 7/25/22 10:21 AM

Emerging from the COVID-19 era, wound care innovation is driven by small players, especially in the digital and diagnostic spaces

In June, wound, ostomy and continence-focused nurses, and supporting industry gathered in Fort Worth, TX for the hybrid WOCNext 2022 conference. In-person attendance was below expectations, but healthy booth time allowed for product discussions with exhibitors.

SmartTRAK observed that product innovation at WOCNext came from smaller companies and those focused on digital and diagnostic solutions not large manufacturers like Smith+Nephew*, 3M* or Mölnlycke*SmartTRAK learned that the large manufacturers are not launching new products for multiple reasons, including supply chain limitations, access to raw materials and the confidence to be able to supply enough products to serve the market.

SmartTRAK is closely watching advances and innovation in the digital and diagnostic space in wound care. Specifically, SmartTRAK Analyst Kris Flinn recently published an article, "The Future of Biosensors and Smart Dressings in Wound Care Diagnostics", available here, highlighting developments in diagnostic biosensors in smart dressings. Additionally, in an early 2022 interview with reimbursement expert Kathleen Schaum, we learned about reimbursement trends that support the development and use of these products. 

Outlined below are several wound diagnostic and digital products prominently highlighted at WOCN.

Topics: Wound Care
Continue Reading
2 min read

Trends in Neurovascular Innovation 2022

By Shelly Caruso on 7/21/22 9:30 AM

Improved aspiration systems, large-bore catheters, balloon-guide catheters and radial access top the list of neurovascular device trends that will continue in 2022.

In the market for mechanical thrombectomy devices, the pace of innovation shows no signs of slowing down in 2022. Manufacturers are designing neurointerventional devices with an eye toward improving first-pass effect, recanalization rates and reducing procedure times to ultimately improve patient outcomes In this article, SmartTRAK highlights recent trends in neurovascular technologies, including variable pressure aspiration systems, large-bore catheters (LBCs), balloon-guide catheters (BGCs) and radial access, as key areas of innovation moving into 2022.

Along with the recent trends in neurovascular technologies, the following topics are covered in detail in this article, which is available for download here:

  • Outgrowing Standard Aspiration Systems
  • Continued Trend Toward Large-Bore Catheters for Access and Aspiration
  • New Designs and Applications for Balloon-Guide Catheters
  • Increasing Competition in Radial Access
Continue Reading
2 min read

SmartTRAK Tip: How to Discover Gaps in your Company's Portfolio

By Thomas Wallick on 7/18/22 9:30 AM

Imagine if you could…
  • See gaps in your product portfolio vs your competitors’ 
  • Discover your next acquisition candidate
  • Find a distribution partner

…in just a few clicks!

BE THE EXPERT who fills in the gaps in your company's portfolio! Read on to view a "How To" video and learn how to outperform your peers and competitors by saving yourself HOURS of research with just ONE search.

That’s the power of SmartTRAK!

For example…

Continue Reading
2 min read

Ending on a Bright Note: Q122 OrthoBio Market Recap

By James Petricek on 7/14/22 9:30 AM

Q122 started slow but ended on a bright note as COVID-19 concerns faded and surgical volumes approached pre-pandemic levels.

Virtually all orthopedic/spine companies experienced the same pattern with elective procedures during the quarter. In general, elective procedure case counts were pressured in January through the beginning of February as a surge in COVID-19 cases impacted patients and contributed to staffing shortages at healthcare facilities. However, by the end of the quarter elective procedures approached or returned to pre-COVID levels.

Among the many topics covered in detail in our comprehensive Q122 OrthoBio Market Recap* are:

Continue Reading
3 min read

Partnering for Success in Neurovascular: Wallaby Medical

By Anne Staylor on 7/12/22 9:30 AM

Wallaby Medical CEO and founder Michael Alper discusses the Company’s recent acquisition of phenox GmBH and positioning the Company for success in an interview with SmartTRAK

With no overlap from a product or geographic perspective, Wallaby Medical’s recent acquisition of phenox GmBH was a “match made in heaven” according to Wallaby’s CEO and founder Michael Alper. In an interview with SmartTRAK, Alper discusses the acquisition, company synergies, complementary channels and the Company’s strategies for global expansion and becoming a leader in the market for neurovascular intervention.

To find out more, including details about the acquisition, the Company and its key products and markets, click on the following video to listen to the interview recorded via Zoom (21:07 min). A link to download the complete transcript of the interview is also provided below.

Continue Reading

    Follow Us on Social Media

    Recent Articles